CIK 0001468748 · Non-accelerated filer<br>Smaller reporting company
Kodiak Sciences Inc.
Sign in to watch- Ticker
- KOD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270476525
- Phone
- 650-281-0850
- Business address
- 1250 PAGE MILL RD, PALO ALTO, CA, 94304
- Former names
- Oligasis, LLC
- Open-market buys, last 90 days
- $181,327,230
- in 4 filings
- Open-market sales, last 90 days
- $2,700,322
- in 1 filing, $2.7M under 10b5-1 plans
Net +$178,626,907. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-12-18 | EHRLICH JASON See Remarks | Option exercise · Restricted Stock Units | −30,000 | 30,000 | ||
| 2019-12-17 | Yang Taiyin Director | Grant or award · Stock Option (Right to Buy) | +8,855 | 8,855 | ||
| 2019-12-06 | BAKER BROS. ADVISORS LP Director | Purchase | +158,180 | $46.00 | $7.3M | 928,360 |
| 2019-12-06 | BAKER BROS. ADVISORS LP Director | Purchase | +1,743,993 | $46.00 | $80.2M | 10,118,929 |
| 2019-12-02 | Liang Hong SVP, Discovery Medicine | Option exercise | +29,250 | $1.04 | $30K | 129,250 |
| 2019-12-02 | Liang Hong SVP, Discovery Medicine | Option exercise | +12,916 | $1.06 | $14K | 142,166 |
| 2019-12-02 | Liang Hong SVP, Discovery Medicine | Option exercise · Stock Option (Right to Buy) | −29,250 | 2,750 | ||
| 2019-12-02 | Liang Hong SVP, Discovery Medicine | Option exercise · Stock Option (Right to Buy) | −12,916 | 7,084 | ||
| 2019-09-19 | BAKER BROS. ADVISORS LP Director | Option exercise | +1 | $0.01 | $0 | 8,374,936 |
| 2019-09-19 | BAKER BROS. ADVISORS LP Director | Option exercise · Common Stock Warrant (right to buy) | −1 | 138,815 | ||
| 2019-07-16 | Liang Hong See Remarks | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2019-07-16 | PERLROTH VICTOR Chairman, President and CEO | Grant or award · Stock Option (Right to Buy) | +241,500 | 241,500 | ||
| 2019-07-16 | BORGESON JOHN A. See Remarks | Grant or award · Stock Option (Right to Buy) | +67,500 | 67,500 | ||
| 2019-07-16 | EHRLICH JASON See Remarks | Grant or award · Stock Option (Right to Buy) | +93,000 | 93,000 | ||
| 2019-06-03 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Option (right to buy) | +24,747 | 24,747 | ||
| 2019-06-03 | Levy Richard S Director | Grant or award · Stock Option (Right to Buy) | +24,747 | 24,747 | ||
| 2019-06-03 | Dahiyat Bassil I Director | Grant or award · Stock Option (Right to Buy) | +24,747 | 24,747 | ||
| 2019-06-03 | PROFUSEK ROBERT Director | Grant or award · Stock Option (Right to Buy) | +24,747 | 24,747 | ||
| 2019-02-07 | Liang Hong See Remarks | Option exercise | +80,000 | $1.04 | $83K | 100,000 |
| 2019-02-07 | Liang Hong See Remarks | Option exercise · Stock Option (Right to Buy) | −80,000 | 32,000 |
Page 35 of 37 · 722 trades